Treatment for Sexually Transmitted Infections
For sexually active adults with STIs, treatment must be pathogen-specific: use ceftriaxone 500 mg IM (or 1 g if ≥150 kg) as monotherapy for gonorrhea, doxycycline 100 mg orally twice daily for 7 days for chlamydia, penicillin G benzathine 2.4 million units IM for early syphilis, valacyclovir for genital herpes, and no specific antiviral treatment exists for HPV (only ablative or immunomodulatory therapies for visible warts). 1, 2
Gonorrhea Treatment
- Ceftriaxone monotherapy is now the standard of care, eliminating the previous dual therapy approach 1
- Dosing is weight-based: 500 mg IM for patients <150 kg, or 1 g IM for patients ≥150 kg 1
- Test-of-cure is mandatory for all pharyngeal gonorrhea cases due to higher treatment failure rates at this site 1
- Antimicrobial resistance has eliminated oral treatment options, making intramuscular ceftriaxone the only reliable first-line therapy 2
Chlamydia Treatment
- Doxycycline 100 mg orally twice daily for 7 days is the preferred regimen, replacing azithromycin as first-line therapy 1, 2
- Azithromycin 1 g orally as a single dose remains an alternative but is no longer preferred 3, 4, 5
- Test-of-cure is required for rectal chlamydia if treated with azithromycin (not needed if doxycycline is used) 1
- Single-dose azithromycin ensures 100% compliance but has lower efficacy than doxycycline 6
Coinfection Considerations
- Patients with gonorrhea should be presumptively treated for chlamydia given high coinfection rates 3, 7
- All patients should be tested for syphilis and HIV at the time of STI diagnosis 7
Syphilis Treatment
- Early syphilis (<1 year duration): penicillin G benzathine 2.4 million units IM as a single dose 1, 2
- Late or unknown duration syphilis: penicillin G benzathine 2.4 million units IM weekly for 3 consecutive weeks 1
- Parenteral penicillin remains the drug of choice for all stages of syphilis 5
- Critical pitfall: Perform thorough evaluation for otic, ophthalmic, and neurologic symptoms before treatment, as neurosyphilis can occur at any stage and requires 10-14 days of IV aqueous crystalline penicillin G 1
Genital Herpes (HSV) Treatment
Initial Episode
- Valacyclovir 1 g orally twice daily for 7-10 days 8, 9
- Treatment should be initiated within 72 hours of symptom onset for maximum efficacy 9
- Alternative agents include acyclovir and famciclovir 5, 10
Recurrent Episodes
- Valacyclovir 500 mg orally twice daily for 5 days, initiated within 24 hours of lesion onset or at first sign of prodrome 8, 9
- Patients should have medication on hand to self-initiate treatment immediately 8
Suppressive Therapy
- Valacyclovir for chronic suppression in immunocompetent adults and HIV-infected patients with CD4+ ≥100 cells/mm³ 9
- Reduces transmission risk in discordant couples 9
Symptomatic Management
- Lidocaine 2-5% gel applied to lesions 3-4 times daily provides local pain relief only 8
- Lidocaine has no antiviral activity and does not prevent transmission or recurrence 8
- Systemic antiviral therapy remains mandatory alongside any symptomatic measures 8
Human Papillomavirus (HPV) Treatment
- No specific antiviral medication exists for HPV eradication 10
- Treatment targets visible genital warts only, not subclinical infection 3
- Therapeutic options are either antimitotic (destructive) or immunomodulatory 10
- Most HPV infections are asymptomatic and self-limited 3
Partner Management and Follow-Up
- All sex partners from the past 60 days must be notified, examined, and treated for diagnosed STIs 3, 7
- Patients and partners must abstain from intercourse for 7 days after single-dose therapy or until completion of multi-day regimens 3, 7
- Retesting at 3 months is recommended to detect reinfection, particularly for gonorrhea and chlamydia 7
- Reinfection is common and difficult to distinguish from treatment failure 3
Special Populations
Pregnancy
- Azithromycin or amoxicillin for chlamydia (doxycycline contraindicated) 7
- Penicillin remains essential for syphilis treatment 5
- Valacyclovir and famciclovir are not yet recommended during pregnancy 5
HIV-Infected Patients
- Same treatment regimens as HIV-negative patients for most STIs 3
- Herpes proctitis may be especially severe in HIV-coinfected patients 3
- Fungi and mycobacteria are more likely causes of complications in immunosuppressed patients 3
Screening Recommendations
- Mandatory annual screening for chlamydia and gonorrhea in all sexually active women <25 years 7
- Screen women ≥25 years with risk factors: new/multiple partners, inconsistent condom use, previous STI, or partner with STI 7
- Use nucleic acid amplification tests (NAATs) as the preferred diagnostic method with sensitivity 86.1-100% and specificity 97.1-100% 7, 2